Breaking the Cycle of Recurrent BV and Thrush: New Research From King's College London
Share
By the BiotaLife Science Team, based on research by Prof Paul Long, Chief Technology Officer at BiotaLife Healthcare and Professor of Pharmacognosy at King's College London

"Published in JAC-Antimicrobial Resistance, July 2025"
For many women, bacterial vaginosis (BV) and thrush are not one-off infections. They come back, sometimes within weeks, and sometimes one follows straight after the other. Recurrent thrush alone affects an estimated 138 million women worldwide every year.¹
New research from King's College London, published in JAC-Antimicrobial Resistance in 2025, points to a different way of approaching the problem: supporting the vaginal microbiome rather than clearing it.²
Why BV and thrush keep coming back
BV is caused by an imbalance in vaginal bacteria, while thrush (vulvovaginal candidiasis) is caused by an overgrowth of Candida yeast. Today, BV is usually managed with prescription antibiotics or over-the-counter acid-containing gels, and thrush with antifungal tablets, creams or gels.
The difficulty is that antibiotics and antifungals act indiscriminately. Alongside the organisms causing symptoms, they can also reduce the protective Lactobacillus bacteria that keep the vaginal environment balanced. Prof Long describes the result as a cycle in which symptoms can pivot between BV and thrush, and in some women both occur at once. Acid-based gels bring their own issues: independent laboratory research found that many over-the-counter lactic acid gels damaged lab-grown vaginal tissue and triggered inflammation.³ And with antimicrobial resistance a growing global concern, relying on ever stronger antimicrobials is not a sustainable answer.
What the study tested
Prof Long's team developed a mucoadhesive hydrogel, which BiotaLife is developing as DuoBalance™, a patented candidate medical device. It contains no antibiotics, antifungals or acids.
In the laboratory, the gel was applied to freshly collected vaginal swabs from women with clinically and laboratory diagnosed BV, thrush, or both. The team used two complementary methods, growing bacteria in culture and analysing their DNA, to answer two questions. Does the gel help Lactobacillus grow and become dominant? And, just as importantly, does it avoid feeding the organisms behind BV and thrush?
What it found
- Lactobacilli recovered. The gel supported regrowth of lactobacilli to levels equivalent to those expected in a healthy vagina.
- The balance of species shifted. DNA analysis showed a move towards Lactobacillus types found in women who are less likely to have repeated episodes of BV or thrush.
-
It outperformed an acid gel. In swabs from women with confirmed BV, the gel supported recovery of significantly more lactobacilli than the market-leading over-the-counter acid-containing vaginal gel.
What this means, and what comes next
These are laboratory results on clinical samples, and they do not yet show how women will respond in everyday use. That is what clinical trials are for, and DuoBalance is now advancing into clinical trials.
What the research does show is a clear direction. Instead of searching for ever more potent antimicrobials, this approach is designed to support the bacteria a woman already has, so her own microbiome can do the work it is built to do. It is the principle behind everything BiotaLife develops: intimate care that works with a woman's body, not against it.


References
- Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet Infectious Diseases. 2018;18(11):e339-e347. https://doi.org/10.1016/S1473-3099(18)30103-8
- Long PF. A new paradigm for treating refractory and recurrent infectious vaginal discharge. JAC-Antimicrobial Resistance. 2025 Jul;7(Suppl 3):dlaf118.017. https://doi.org/10.1093/jacamr/dlaf118.017
- Tyssen D, Hearps AC, Guntur K, et al. The impact of over-the-counter lactic acid containing vaginal gels on the integrity and inflammatory state of the vaginal epithelium in vitro. Frontiers in Reproductive Health. 2022;4:915948. https://doi.org/10.3389/frph.2022.915948
FAQ
Can you have BV and thrush at the same time?
Yes. BV is caused by a bacterial imbalance and thrush by Candida yeast, but the two can occur together, and some women find symptoms switch from one to the other after treatment. Because the symptoms overlap, a GP, sexual health clinic or pharmacist can help confirm what is causing them.
What counts as recurrent thrush or BV?
Thrush is usually considered recurrent when a woman has four or more episodes in a year. BV also frequently returns after treatment. If symptoms keep coming back, it is worth seeing a GP or sexual health clinic, as recurring symptoms may need a different approach from a single episode.
What is microbiome remodelling?
Microbiome remodelling means supporting the vaginal microbiome to shift back towards a balance dominated by protective Lactobacillus bacteria, rather than simply killing the organisms causing symptoms. It is the approach behind Prof Paul Long's research at King's College London and BiotaLife's DuoBalance candidate medical device.
What did the King's College London study find?
In laboratory tests on vaginal swabs from women with diagnosed BV and thrush, a mucoadhesive hydrogel supported regrowth of lactobacilli to healthy levels and shifted species towards types linked with fewer repeat episodes. It also supported significantly more lactobacilli than a market-leading acid gel in BV samples.
Does this research show DuoBalance works in women?
Not yet. The study was carried out in the laboratory using swabs collected from women, which is an important early step but not the same as testing in everyday use. DuoBalance is now advancing into clinical trials, which are designed to answer exactly that question.
Why does antimicrobial resistance matter for vaginal health?
When bacteria and fungi are repeatedly exposed to antibiotics and antifungals, some can become resistant, making future infections harder to manage. Because BV and thrush often recur, women may receive many courses over time. Approaches that contain no antibiotics or antifungals are designed not to add to that pressure.
Is DuoBalance available to buy?
No. DuoBalance™ is a patented, antibiotic-free and acid-free candidate medical device being developed by BiotaLife Healthcare. It is now advancing into clinical trials and is not yet approved or available to buy.
Who is Prof Paul Long?
Prof Paul Long is Professor of Pharmacognosy at King's College London and Chief Technology Officer at BiotaLife Healthcare. He has more than 35 years of research and industry experience in life sciences and pharmaceuticals, and leads the research behind BiotaLife's microbiome-first approach to BV and thrush.